Deutsche Bank initiated coverage of Circassia Group with a Hold rating and 250 GBp price target. The analyst says the company specializes in the manufacture of vectors to deliver genetic material using a range of viruses to enhance the disease-fighting capabilities of donor or patient’s cells.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSSPF: